This pathway operates independently of Glutathione Peroxidase 4 (GPX4), another primary regulator of ferroptosis, suggesting an alternative method through which SMURF2 can enhance ferroptotic susceptibility in cancer cells (103). The gene discussed is GPX4; the disease is cancer.